Biological Therapy Approaches in Colorectal Cancer
Author Information
Author(s): AP Zbar, NR Lemoine, M Wadhwa, H Thomas, D Snary, WA Kmiot
Primary Institution: Hammersmith Hospital, London, UK
Hypothesis
Can carcinoembryonic antigen (CEA) be enhanced as an immunogenic target in colorectal cancer treatment?
Conclusion
Immunotherapeutic strategies targeting CEA have shown potential in improving disease-free survival in colorectal cancer patients.
Supporting Evidence
- Over 50% of colorectal cancer patients have occult metastatic disease at the time of surgery.
- Immunotherapeutic strategies have shown limited success but are gaining renewed interest.
- Recent studies indicate that CEA can be a target for immunotherapy in colorectal cancer.
Takeaway
This study looks at how a specific protein called CEA can be used to help treat colorectal cancer by making the immune system recognize and attack cancer cells better.
Methodology
The review discusses various immunotherapeutic strategies and their effectiveness in targeting CEA in colorectal cancer.
Limitations
The review does not provide specific clinical trial data or detailed statistical analyses.
Want to read the original?
Access the complete publication on the publisher's website